Jeffrey Hsu

Jeff is co-founder and CEO of Ivy Natal. He previously led bioinformatics at a preimplantation genetic diagnosis (PGD) startup and did postdoctoral research at the Cleveland Clinic on the genomic basis of heart disease. He received his PhD in Molecular Medicine from Case Western Reserve University.